Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking single cell analysis techniques to clinical diagnosis, drug development, and health management. The company was incorporated in January 2018 and currently has offices and laboratories in Nanjing, Suzhou, US, and Germany.
Singleron obtained a worldwide exclusive IP license from Yale University for its uniquely designed microfluidic single cell processing device, and has developed the innovative GEXSCOPE® single cell system based on this microfluidic device. The GEXSCOPE® system offers a single cell analysis product format that is highly suitable for clinical applications by addressing typical challenges in single cell sequencing workflow, such as difficult sample transport, complicated procedure, and high cost. Since its incorporation, Singleron has quickly developed key proprietary technologies and methods on microfluidic system design, tissue processing, single cell barcoding and amplification, data analysis algorithms, data mining, and database construction, and applied for over thirty patents and obtained Twenty-seven software copyrights. GEXSCOPE® Single Cell RNA reagents and consumables, which enable RNA-seq library construction from thousands of single cells in parallel, were successfully launched in January 2019. The company has already worked with over 100 prominent research institutes, hospitals, and pharmaceutical companies, both in China and oversees, to promote the adoption of innovative single cell analysis technologies in clinics and drug discovery.
WeChat Official Account
Suite 4704, Central Plaza, 18 Harbour Road, Wanchai, Hong Kong
Tel:852 3520 0635
©️ 2020 All Rights Reserved 晨岭资本有限公司 版权所有 粤ICP备2020113789号